Citigroup
SLS icon

Citigroup’s SELLAS Life Sciences SLS Stock Holding History

Citigroup’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82M Buy
326,591
+300,945
+1,173% +$2.08M ﹤0.01% 2170
2026
Q1 		$108K Sell
25,646
-29,829
-54% -$133K ﹤0.01% 4251
2025
Q4 		$209K Buy
55,475
+51,201
+1,198% +$99.5K ﹤0.01% 3987
2025
Q3 		$6.88K Sell
4,274
-38,141
-90% -$67.9K ﹤0.01% 5130
2025
Q2 		$92.9K Buy
+42,415
New +$65.1K ﹤0.01% 4441
2023
Q1 		– Sell
-100
Closed -$236 – 5825
2022
Q4 		$236 Buy
+100
New +$280 ﹤0.01% 5584
2022
Q2 		– Sell
-1,918
Closed -$13K – 6623
2022
Q1 		$13K Buy
+1,918
New +$11.2K ﹤0.01% 5403
2019
Q1 		– Sell
-12
Closed -$1K – 7788
2018
Q4 		$1K Hold
12
– – ﹤0.01% 7594
2018
Q3 		$1K Hold
12
– – ﹤0.01% 7680
2018
Q2 		$2K Hold
12
– – ﹤0.01% 7475
2018
Q1 		$2K Buy
+12
New +$3.43K ﹤0.01% 7378
2017
Q4 		– Sell
-3
Closed -$2K – 7641
2017
Q3 		$2K Sell
3
-2
-40% -$1.32K ﹤0.01% 7038
2017
Q2 		$4K Buy
5
+2
+67% +$1.74K ﹤0.01% 6823
2017
Q1 		$3K Sell
3
-4
-57% -$6.62K ﹤0.01% 6940
2016
Q4 		$22K Buy
+7
New +$40.7K ﹤0.01% 6496

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citigroup's SLS Position: Q2 2026 in Review

Citigroup increased its SELLAS Life Sciences (SLS) stake by 1,173% in Q2 2026, buying an estimated $2.08M and bringing the position to 326,591 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Citigroup first reported a position in SLS in Q4 2016 and has held it in 15 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Citigroup held 326,591 shares of SELLAS Life Sciences worth $4.82M as of Q2 2026.
  • Citigroup bought 300,945 SELLAS Life Sciences shares in Q2 2026, an estimated $2.08M.
  • SELLAS Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2170 holding.
  • Citigroup first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 15 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.